Literature DB >> 22846948

The utility of procalcitonin in critically ill trauma patients.

Joseph V Sakran1, Christopher P Michetti, Michael J Sheridan, Robyn Richmond, Tarek Waked, Tayseer Aldaghlas, Anne Rizzo, Margaret Griffen, Samir M Fakhry.   

Abstract

BACKGROUND: Procalcitonin (PCT), the prohormone of calcitonin, has an early and highly specific increase in response to systemic bacterial infection. The objectives of this study were to determine the natural history of PCT for patients with critical illness and trauma, the utility of PCT as a marker of sepsis versus systemic inflammatory response syndrome (SIRS), and the association of PCT level with mortality.
METHODS: PCT assays were done on eligible patients with trauma admitted to the trauma intensive care unit (ICU) of a Level I trauma center from June 2009 to June 2010, at hours 0, 6, 12, 24, and daily until discharge from ICU or death. Patients were retrospectively diagnosed with SIRS or sepsis by researchers blinded to PCT results.
RESULTS: A total of 856 PCT levels from 102 patients were analyzed, with mean age of 49 years, 63% male, 89% blunt trauma, mean Injury Severity Score of 21, and hospital mortality of 13%. PCT concentration for patients with sepsis, SIRS, and neither were evaluated. Mean PCT levels were higher for patients with sepsis versus SIRS (p < 0.0001). Patients with a PCT concentration of 5 ng/mL or higher had an increased mortality when compared with those with a PCT of less than 5 ng/mL in a univariate analysis (odds ratio, 3.65; 95% confidence interval, 1.03-12.9; p = 0.04). In a multivariate logistic analysis, PCT was found to be the only significant predictor for sepsis (odds ratio, 2.37; 95% confidence interval,1.23-4.61, p = 0.01).
CONCLUSION: PCT levels are significantly higher in ICU patients with trauma and sepsis and may help differentiate sepsis from SIRS in critical illness. An elevated PCT level was associated with increased mortality.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22846948     DOI: 10.1097/TA.0b013e31825ff5b7

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  19 in total

1.  Predictive Values of Procalcitonin and Presepsin for Acute Kidney Injury and 30-Day Hospital Mortality in Patients with COVID-19.

Authors:  Sin-Young Kim; Dae-Young Hong; Jong-Won Kim; Sang-O Park; Kyeong-Ryong Lee; Kwang-Je Baek
Journal:  Medicina (Kaunas)       Date:  2022-05-28       Impact factor: 2.948

2.  Procalcitonin is a prognosis biomarker in very preterm neonates with late onset sepsis: a pilot study.

Authors:  Valerie Ruetsch; Simon Barreault; Nolwenn Le Sache; Pierre Tissères
Journal:  Eur J Pediatr       Date:  2021-11-30       Impact factor: 3.860

Review 3.  Clinical Applications of Procalcitonin in Pediatrics: An Advanced Biomarker for Inflammation and Infection-Can It Also Be Used in Trauma?

Authors:  Ioannis Koutroulis; Steven M Loscalzo; Panagiotis Kratimenos; Sabina Singh; Evan Weiner; Vassiliki Syriopoulou; Stamatios Theocharis; Georgios Chrousos
Journal:  Int Sch Res Notices       Date:  2014-10-28

4.  Procalcitonin kinetics - prognostic and diagnostic significance in septic patients.

Authors:  Małgorzata Lipińska-Gediga; Magdalena Mierzchała-Pasierb; Grażyna Durek
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

5.  Biomarkers to Guide the Timing of Surgery: Neutrophil and Monocyte L-Selectin Predict Postoperative Sepsis in Orthopaedic Trauma Patients.

Authors:  Gabrielle Daisy Briggs; Karla Lemmert; Natalie Jane Lott; Theo de Malmanche; Zsolt Janos Balogh
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

6.  Procalcitonin Assay Has No Role in the Routine Assessment of Severe Trauma Patients at Admission to the Emergency Department.

Authors:  Vijaya S Lakshmi; Anusha Cherian; Prashant Adole
Journal:  Cureus       Date:  2021-07-07

7.  Perceptions of point-of-care infectious disease testing among European medical personnel, point-of-care test kit manufacturers, and the general public.

Authors:  Wendy E Kaman; Eleni-Rosalina Andrinopoulou; John P Hays
Journal:  Patient Prefer Adherence       Date:  2013-06-19       Impact factor: 2.711

Review 8.  Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit.

Authors:  John Alfred Carr
Journal:  J Intensive Care       Date:  2015-08-04

Review 9.  Revolutionising bacteriology to improve treatment outcomes and antibiotic stewardship.

Authors:  David M Livermore; John Wain
Journal:  Infect Chemother       Date:  2013-03-29

10.  Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study.

Authors:  Nonika Rajkumari; Purva Mathur; Satyapriya Sharma; Babita Gupta; Sanjeev Bhoi; Mahesh C Misra
Journal:  J Lab Physicians       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.